Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
2003-5-14
pubmed:abstractText
There is now much data that suggest a relationship between angiogenesis and breast cancer prognosis. Angiogenesis is a multistep process resulting from an ordered set of events and regulated by positive and negative modulators of microvessels growth and by the expression of various proteolytic enzymes.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Antigens, CD, http://linkedlifedata.com/resource/pubmed/chemical/Antigens, CD34, http://linkedlifedata.com/resource/pubmed/chemical/Endothelial Growth Factors, http://linkedlifedata.com/resource/pubmed/chemical/Intercellular Signaling Peptides..., http://linkedlifedata.com/resource/pubmed/chemical/Lymphokines, http://linkedlifedata.com/resource/pubmed/chemical/Plasminogen Activator Inhibitor 1, http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Estrogen, http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Progesterone, http://linkedlifedata.com/resource/pubmed/chemical/Urokinase-Type Plasminogen Activator, http://linkedlifedata.com/resource/pubmed/chemical/Vascular Endothelial Growth Factor A, http://linkedlifedata.com/resource/pubmed/chemical/Vascular Endothelial Growth Factors
pubmed:status
MEDLINE
pubmed:month
Apr
pubmed:issn
0735-7907
pubmed:author
pubmed:issnType
Print
pubmed:volume
21
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
208-16
pubmed:dateRevised
2008-11-21
pubmed:meshHeading
pubmed-meshheading:12743986-Adult, pubmed-meshheading:12743986-Aged, pubmed-meshheading:12743986-Aged, 80 and over, pubmed-meshheading:12743986-Antigens, CD, pubmed-meshheading:12743986-Antigens, CD34, pubmed-meshheading:12743986-Breast Neoplasms, pubmed-meshheading:12743986-Chemotherapy, Adjuvant, pubmed-meshheading:12743986-Cytosol, pubmed-meshheading:12743986-Endothelial Growth Factors, pubmed-meshheading:12743986-Female, pubmed-meshheading:12743986-Follow-Up Studies, pubmed-meshheading:12743986-Humans, pubmed-meshheading:12743986-Intercellular Signaling Peptides and Proteins, pubmed-meshheading:12743986-Lymphatic Metastasis, pubmed-meshheading:12743986-Lymphokines, pubmed-meshheading:12743986-Middle Aged, pubmed-meshheading:12743986-Neoplasm Staging, pubmed-meshheading:12743986-Plasminogen Activator Inhibitor 1, pubmed-meshheading:12743986-Predictive Value of Tests, pubmed-meshheading:12743986-Prognosis, pubmed-meshheading:12743986-Receptors, Estrogen, pubmed-meshheading:12743986-Receptors, Progesterone, pubmed-meshheading:12743986-Recurrence, pubmed-meshheading:12743986-Regression Analysis, pubmed-meshheading:12743986-Time Factors, pubmed-meshheading:12743986-Urokinase-Type Plasminogen Activator, pubmed-meshheading:12743986-Vascular Endothelial Growth Factor A, pubmed-meshheading:12743986-Vascular Endothelial Growth Factors
pubmed:year
2003
pubmed:articleTitle
A high cytosol value of urokinase-type plasminogen activator (uPA) may be predictive of early relapse in primary breast cancer.
pubmed:affiliation
Oncology and Hematology Department, Ospedale Santa Maria delle Croci, Viale Randi 5, 48100 Ravenna, Italy. dazzicla@laserinforma.com
pubmed:publicationType
Journal Article